In an article published in PLOS Pathogens, they describe potential pharmaceutical targets for the treatment of visceral leishmaniasis. Existing therapeutic strategies are considered insufficiently ...
Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for the ...